Rabia Gurses Ozden

OCUL

Rabia Gurses Ozden serves as Chief Medical Officer at Ocular Therapeutix, Inc. (OCUL). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

0 trades

$0.00

Total Sells

4 trades

$100.6K

Net Position

Net Seller

$100.6K

Companies Traded

OCUL

Active Period

Feb 2023 – Feb 2024

4 total trades

Most Recent

Sell OCUL

Feb 6, 2024 · $30.8K

Rabia Gurses Ozden's Insider Trading at Ocular Therapeutix, Inc. (OCUL)

Buys

0 · $0.00

Sells

4 · $100.6K

Total Shares Bought

Total Shares Sold

21,358

OCUL Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Feb 6, 2024	Sell	6,346	$4.86	$30.8K	153,054
Feb 2, 2024	Sell	7,764	$4.95	$38.4K	92,767
Jul 11, 2023	Sell	832	$4.93	$4.1K	100,531
Feb 8, 2023	Sell	6,416	$4.24	$27.2K	101,363

Related Insiders

Peter Kaiser

officer: Chief Development Officer

OCULSell · Feb 25, 2026

Pravin Dugel

See Remarks

OCULSell · Feb 25, 2026

Jeffrey S. Heier

officer: Chief Scientific Officer

OCULSell · Feb 25, 2026

Sanjay Nayak

officer: Chief Strategy Officer

OCULSell · Feb 25, 2026

Nadia Waheed

Chief Medical Officer

OCULSell · Feb 12, 2026

Donald Notman

See Remarks

OCULSell · Feb 12, 2026

Namrata Saroj

Chief Business Officer

OCULSell · Nov 7, 2025

Todd Anderman

Chief Legal Officer

OCULSell · Oct 10, 2025

Explore More Insider Trading Data

OCUL Insider Trading Activity

View all insider trades at Ocular Therapeutix, Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity